Advertisement
VoSpire ER(R) is indicated for the relief of bronchospasm in adults andchildren 6 years of age and older with reversible obstructive airway disease.
Advertisement
"We at DAVA felt that the DoctorDirectory team and the IncreaseRx solutionwere an excellent fit for the continued promotion of VoSpire ER(R). Thestrength of IncreaseRx is in its ability to reach far more prescribers than wecould have by utilizing a traditional sales force model. The value-basedrelationship that DoctorDirectory has with its physicians gives our brand aparticularly attractive solution," said Liad Spiro, Senior Director,Commercialization and Marketing for DAVA.
DoctorDirectory is a marketing solutions company that specializes inproviding brand teams and their agencies web-based access to HealthcareProfessionals. IncreaseRx is a whitespace strategy designed to reachunder-performing or inaccessible physician segments and generate incrementalrevenue from unrealized potential. It utilizes a suite of traditional andweb-based tactics to generate incremental revenue for any pharma brandregardless of product life cycle.
For more information about DoctorDirectory or IncreaseRx, contact JayGrobowsky at 828-255-0252 or by email at [email protected].
DAVA Pharmaceuticals, Inc. is a global pharmaceutical company committed toproviding cost-effective pharmaceutical products to the healthcare market byintegrating expertise in product development, manufacturing and marketing withglobal strategic alliances to deliver medicines from the source.
For more information about DAVA Pharmaceuticals, Inc., contact Liad Spiroat 201-947-7442 or by email at [email protected].
This release was issued through eReleases(TM). For more information,visit http://www.ereleases.com.
SOURCE DoctorDirectory.com, Inc.
